ARC-20: Casdatifan for Patients With Previously Treated ccRCC | GU Oncology Now
Dr. McGregor explains the safety, efficacy, and subgroup analysis from ARC-20 in patients with previously treated ccRCC.
Related Articles
ASCO 2025: Data on Lung Cancer Biomarker Testing in North America
The IASLC study showed that 40% of respondents in North America indicate that treatment for lung cancer is often initiated before receipt of the results…
Marketing Disguised as Science Embarrasses Everyone Involved
A prominent medical journal embarrrasses itself by publishing a flawed study from the American Board of Internal Medicine. Critical appraisal lessons are obvious.
Are You Skipping Breakfast? Eating Late? You May Want to Reconsider: Joel Kahn, MD: Integrative Cardiologist
The data suggest that adopting the habit of eating earlier first and last meals with a longer period of night-time fasting could help to prevent…
How Coffee Can Help You Live Longer – As Long As You Keep It Simple
Researchers studied the coffee habits and health outcomes of 46,000 adults
Vegan in Paris: Is It Really That Hard? A Food Vlog Breakdown
If you’re visiting Paris and want to know how vegan-friendly the city is, here’s where to find plant-based food and restaurants.
Bloomberg – Business News, Stock Markets, Finance, Breaking & World News
Bloomberg delivers business and markets news, data, analysis, and video to the world, featuring stories from Businessweek and Bloomberg News
Association between soy products and prostate cancer: A systematic review and meta-analysis of observational studies – PubMed
The consumption of soy products can reduce the overall risk of PCA among men. Various factors, including soy products-related factors (e.g., consumption, frequency), population-related factors…
The Truth About Heart Disease and Nutrition with Dr. Joel Kahn
Podcast Episode · Plant Based Coaches · 06/21/2025 · 49m
‘The HemOnc Pulse’ Live: Controversies in MDS | Blood Cancers Today
Recorded at HemOnc Pulse Live in Austin, experts join Naval Daver, MD, to discuss major controversies in MDS care, including frontline and novel therapies, and…
Pilot Study of Early Catheter Ablation and Neurological Outcomes in Atrial Fibrillation-Related Stroke: RESCUE-STROKE
AbstractBackgroundInadequate management of atrial fibrillation (AF) after stroke is associated with a worse prognosis, and the impact of early rhythm control with catheter ablation (CA)…
